Purchase Order W81XWH17P0053

This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Pacific Immunology, a for-profit biotech company in Ramona, California. The contract is for monospecific antibody production services, with a ceiling value of $19,297.50 and a period of performance ending on September 30, 2025. The contract does not have a set-aside designation. Pacific Immunology is the prime...

This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), to Pacific Immunology, a USA-based biotech company located in Ramona, California. The contract is for the production of monospecific antibodies, with a ceiling value of $4,321.60 and an ultimate completion date of March 10, 2010. The contract does not utilize a set-aside designation. Pacific Immunology, the prime...

Pacific Immunology, a specialized biotech firm based in Ramona, California, received a $3,687.05 firm fixed-price purchase order from a civilian federal agency (Pacific West Area) for immunological research services. The contract, awarded on July 31, 2019, with an ultimate completion date of August 30, 2019, encompasses multiple deliverables including immunograde peptide synthesis ($580.00), exsanguination bleeds for rabbits ($120.00), and rabbit procurement ($2,990.00), with a volume discount...

This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $31,435.00 contract is for the production of 20 liters of monoclonal antibodies at $1,500 per liter. This award supports NIAID's infectious disease research efforts, leveraging Geneimmune's expertise in areas such as gene...

Pacific Immunology has been awarded a $19,813 purchase order contract by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to provide antibody production testing services in support of the agency's biomedical research efforts. The firm fixed price contract runs from September 2023 through September 2024 and will be performed in Ramona, California. No subcontractors or set aside designations were identified. This award...

This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products, specifically blood typing, compatibility testing, and antibody screening reagents and consumables. The $137,483.05 contract has an ultimate completion date of December 31, 2027 and does not utilize any set-aside designations. Immucor is a key supplier of specialized blood banking technologies and supplies to federal healthcare...

Immucor Inc. has been awarded a $122,190.27 firm fixed price delivery order by the Department of the Air Force Air Education and Training Command to provide FSC 6550 in vitro diagnostic reagents. The contract has no set-aside designation and requires performance through September 30, 2023 at Keesler Air Force Base in Mississippi. As a leading provider of blood banking products and services, Immucor supports critical transfusion medicine operations through multiple award schedule contracts and...

This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) to Pacific Immunology, a U.S. biotech company located in Ramona, California. The $4,436.81 contract is for the production and delivery of monospecific antibodies and related services to support biomedical research. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of NIH, and does not utilize a small business set-aside. The services to...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $17,705 firm fixed-price purchase order to Pacific Immunology on August 15, 2023, under the FY26 UDO Initiative (AMBIS #2183793). The contract, which carries no set-aside designation, is scheduled for completion by December 31, 2023, and will be performed at Pacific Immunology's facility in Ramona, California. Pacific Immunology, a specialized biotech company registered in the System for Award Management since October...

Immucor Inc. was awarded a firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency (DHA) to provide rapid screen, complement control cells, Panocell, and Immucor reagents. The contract has a potential value of $20,000 and requires delivery to Fort Belvoir, Virginia by November 9, 2021. No set-aside designation was used for this award made under an existing BPA. The reagents will support DHA's medical laboratory testing programs. Immucor will serve as the...